|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
32,633,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,434,166 |
Avg
Vol: |
650,831 |
52
Week Range: |
$21.74 - $21.74 |
|
Level
I Sector: |
Industrials |
Level
II Sector: |
Diversified Services |
Level
III Sector: |
Research Services |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2008-05-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
4,619,428 |
|
- |
|
D Ambra Constance M |
10% Owner |
|
2008-05-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
4,619,428 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2008-05-14 |
5 |
GD |
$0.00 |
$0 |
D/D |
6,988 |
4,619,428 |
|
- |
|
D Ambra Constance M |
10% Owner |
|
2008-05-14 |
5 |
GD |
$0.00 |
$0 |
D/D |
6,988 |
4,619,428 |
|
- |
|
Frost Mark T |
Chief Financial Officer |
|
2008-03-17 |
4 |
A |
$11.21 |
$44,840 |
D/D |
4,000 |
31,600 |
|
- |
|
Roth Arthur J |
Director |
|
2008-02-15 |
4 |
B |
$10.53 |
$10,530 |
D/D |
1,000 |
15,000 |
2.39 |
- |
|
Jennings William Steven |
Senior Vice PresidentOfficer |
|
2008-02-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2007-12-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
4,638,416 |
|
- |
|
D Ambra Constance M |
10% Owner |
|
2007-12-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
4,638,416 |
|
- |
|
Roth Arthur J |
Director |
|
2007-12-04 |
4 |
B |
$12.67 |
$25,340 |
D/D |
2,000 |
14,000 |
2.39 |
- |
|
Oconnor Kevin |
Director |
|
2007-11-20 |
4 |
B |
$12.79 |
$15,273 |
D/D |
1,193 |
10,321 |
2.39 |
- |
|
Jordan Veronica Gh |
Director |
|
2007-11-19 |
4 |
B |
$12.00 |
$30,000 |
D/D |
2,500 |
4,805 |
2.39 |
- |
|
Oconnor Kevin |
Director |
|
2007-11-16 |
4 |
B |
$12.58 |
$12,895 |
D/D |
1,025 |
9,128 |
2.39 |
- |
|
Frost Mark T |
Chief Financial Officer |
|
2007-11-09 |
4 |
B |
$12.18 |
$30,450 |
D/D |
2,500 |
27,600 |
2.74 |
- |
|
Tartaglia Anthony P |
Director |
|
2007-09-06 |
4 |
S |
$15.30 |
$173,268 |
D/D |
(11,250) |
32,411 |
|
- |
|
Tartaglia Anthony P |
Director |
|
2007-09-06 |
4 |
OE |
$4.44 |
$49,950 |
D/D |
11,250 |
43,661 |
|
- |
|
Oconnor Kevin |
Director |
|
2007-06-04 |
4 |
A |
$14.47 |
$15,005 |
D/D |
1,037 |
8,103 |
|
- |
|
Jordan Veronica Gh |
Director |
|
2007-06-04 |
4 |
A |
$14.47 |
$15,005 |
D/D |
1,037 |
2,305 |
|
- |
|
Ryan Una S |
Director |
|
2007-06-04 |
4 |
A |
$14.47 |
$29,996 |
D/D |
2,073 |
4,608 |
|
- |
|
Kuhla Donald E |
Director |
|
2007-06-04 |
4 |
A |
$14.47 |
$15,005 |
D/D |
1,037 |
127,183 |
|
- |
|
Tartaglia Anthony P |
Director |
|
2007-06-04 |
4 |
A |
$14.47 |
$29,996 |
D/D |
2,073 |
32,411 |
|
- |
|
Anderson Paul S |
Director |
|
2007-06-04 |
4 |
A |
$14.47 |
$15,005 |
D/D |
1,037 |
5,219 |
|
- |
|
Roth Arthur J |
Director |
|
2007-06-04 |
4 |
A |
$14.47 |
$14,470 |
D/D |
1,000 |
12,000 |
|
- |
|
Evans Johnathan D |
VP Pharma Dev & Manu |
|
2007-03-23 |
4 |
A |
$10.02 |
$200,400 |
D/D |
20,000 |
20,000 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2007-03-13 |
4 |
GD |
$9.50 |
$218,709 |
D/D |
23,022 |
4,647,416 |
|
- |
|
620 Records found
|
|
Page 21 of 25 |
|
|